BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23530474)

  • 1. Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction.
    Sörensson P; Rydén L; Saleh N; Tornvall P; Arheden H; Pernow J
    BMC Cardiovasc Disord; 2013 Mar; 13():22. PubMed ID: 23530474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial.
    Limalanathan S; Andersen GØ; Kløw NE; Abdelnoor M; Hoffmann P; Eritsland J
    J Am Heart Assoc; 2014 Apr; 3(2):e000679. PubMed ID: 24760962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
    Sörensson P; Saleh N; Bouvier F; Böhm F; Settergren M; Caidahl K; Tornvall P; Arheden H; Rydén L; Pernow J
    Heart; 2010 Nov; 96(21):1710-5. PubMed ID: 20956486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction.
    Stiermaier T; Jensen JO; Rommel KP; de Waha-Thiele S; Fuernau G; Desch S; Thiele H; Eitel I
    Circ Res; 2019 May; 124(10):1482-1491. PubMed ID: 30929570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction.
    Garcia S; Henry TD; Wang YL; Chavez IJ; Pedersen WR; Lesser JR; Shroff GR; Moore L; Traverse JH
    J Cardiovasc Transl Res; 2011 Feb; 4(1):92-8. PubMed ID: 21136310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement in left ventricular systolic function in patients with first anterior ST‑segment elevation myocardial infarction.
    Elżbieciak M; Wita K; Grabka M; Chmurawa J; Doruchowska A; Turski M; Filipecki A; Wybraniec M; Mizia-Stec K
    Pol Arch Med Wewn; 2013; 123(6):268-76. PubMed ID: 23674047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic Postconditioning Confers No Benefit to Left Ventricular Systolic Function: A Meta-Analysis of Cardiac Magnetic Resonance Imaging Results.
    Bergman I; Boyle D; Braver O; Gelikas S; Wexler Y; Omelchenko A; Assali A; Nussinovitch U
    Am J Cardiol; 2023 Dec; 208():126-133. PubMed ID: 37837795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.
    Eitel I; Stiermaier T; Rommel KP; Fuernau G; Sandri M; Mangner N; Linke A; Erbs S; Lurz P; Boudriot E; Mende M; Desch S; Schuler G; Thiele H
    Eur Heart J; 2015 Nov; 36(44):3049-57. PubMed ID: 26385956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.
    Wöhrle J; Merkle N; Kunze M; Cristea E; Mehran R; Rottbauer W; Stone GW
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1083-9. PubMed ID: 22162175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis.
    Wang L; Wang J; Xu H; Li B
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E662-71. PubMed ID: 23804529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention.
    Freixa X; Bellera N; Ortiz-Pérez JT; Jiménez M; Paré C; Bosch X; De Caralt TM; Betriu A; Masotti M
    Eur Heart J; 2012 Jan; 33(1):103-12. PubMed ID: 21846677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial.
    Kim EK; Hahn JY; Song YB; Lee SC; Choi JH; Choi SH; Lee SH; Choe YH; Gwon HC
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):629-37. PubMed ID: 25589306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
    Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
    Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
    Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
    Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).
    Eitel I; Friedenberger J; Fuernau G; Dumjahn A; Desch S; Schuler G; Thiele H
    Clin Res Cardiol; 2011 May; 100(5):425-32. PubMed ID: 21125288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.